Cargando…
Gadolinium-induced nephrogenic systemic fibrosis: the rise and fall of an iatrogenic disease
BACKGROUND. In 2006, nephrologists in Denmark unexpectedly identified chronic kidney disease (CKD) patients with a new syndrome, nephrogenic systemic fibrosis (NSF). Subsequently, 1603 NSF patients were reported to the Food and Drug Administration. Sixty hospitals in the USA account for 93% of these...
Autores principales: | Bennett, Charles L., Qureshi, Zaina P., Sartor, A. Oliver, Norris, LeAnn B., Murday, Alanna, Xirasagar, Sudha, Thomsen, Henrik S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341839/ https://www.ncbi.nlm.nih.gov/pubmed/22833806 http://dx.doi.org/10.1093/ckj/sfr172 |
Ejemplares similares
-
Nephrogenic systemic fibrosis (NSF): a late adverse reaction to some of the gadolinium based contrast agents
por: Thomsen, Henrik S., et al.
Publicado: (2007) -
Gadolinium and nephrogenic systemic fibrosis: time to tighten practice
por: Mendichovszky, Iosif A., et al.
Publicado: (2007) -
Chelation of gadolinium with deferoxamine in a patient with nephrogenic systemic fibrosis
por: Leung, Nelson, et al.
Publicado: (2009) -
Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide
por: Thomsen, Henrik S.
Publicado: (2006) -
A Case of Delayed Onset Nephrogenic Systemic Fibrosis After Gadolinium Based Contrast Injection
por: Do, Jong Geol, et al.
Publicado: (2012)